Video

Focus on preventing comorbidities in MS, physician urges


 

REPORTING FROM THE CMSC ANNUAL MEETING

– Some patients use multiple sclerosis as an excuse to make poor health choices, but Allen C. Bowling, MD, PhD, of the Colorado Neurological Institute has seen another kind of story unfold. Fifteen to 20 years ago, Dr. Bowling said, he treated patients who took the development of MS in their 20s as a sign they needed to take better care of themselves. “They said MS was the best thing that happened to them ‘because it motivated me to make these healthy lifestyle changes I wouldn’t have made otherwise.’ ”

These patients have maintained their lifestyle changes, he said, lowering their risk of comorbidities and – perhaps – changing the course of their MS for the better.

“It’s all one machine, and sometimes we lose sight of that in our sub-sub-specialized world of treating MS ... You’re caring for a whole person. If you start thinking about that, it does make you think differently about how you treat the person, how you try to prevent disease in terms of certain pathways,” Dr. Bowling said in an interview at the annual meeting of the Consortium of Multiple Sclerosis Centers, where he spoke to colleagues about the importance of helping patients to adopt lifestyle changes.

According to Dr. Bowling, there’s evidence linking lifestyle-related comorbidities, poorer food quality, and tobacco use to higher levels of overall MS risk, relapses, disability, and symptoms.

Researchers have also linked other life factors to higher MS risks: obesity (linked to overall MS risk, disability, symptoms); lack of physical activity (linked to relapses, disability, symptoms); emotional factors (relapses, symptoms); and alcohol overuse (linked to overall risk, disability, symptoms).

“Data is mild to moderate to strong in all those areas for lifestyle approaches like diet, physical activity, emotional health, alcohol in moderation or less, and no tobacco smoking,” Dr. Bowling said.

Pages

Recommended Reading

VIDEO: Managing the alemtuzumab paradox
MDedge Internal Medicine
Nearly half of MS patients treated by primary docs miss out on meds
MDedge Internal Medicine
Physicians often bypass cognition, depression screening in MS
MDedge Internal Medicine
Study identifies characteristics that may constitute the MS prodrome
MDedge Internal Medicine
MS medication withdrawn because of safety concerns
MDedge Internal Medicine
The case for being open-minded about medical marijuana
MDedge Internal Medicine
Siponimod trial ‘first’ to show delayed disability in secondary progressive MS
MDedge Internal Medicine
VIDEO: AAN MS guidelines aim to help clinicians weigh expanding drug choices
MDedge Internal Medicine
Ocrelizumab safety update: Encouraging rates of serious infection, malignancy
MDedge Internal Medicine
Research on exercise in MS needs to build up some muscle
MDedge Internal Medicine